THOUSAND OAKS Calif.ÂDec. 6 2019ÂPRNewswire &8212;ÂAmgenÂNASDAQAMGN today announced that theÂU.S. Food and Drug AdministrationÂFDA has approved AVSOLA infliximabaxxq for all approved indications of the reference product RemicadeÂÂinfliximab for the tre...
↧